4.6 Article

Resveratrol improves prostate fibrosis during progression of urinary dysfunction in chronic prostatitis

期刊

ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
卷 54, 期 -, 页码 120-124

出版社

ELSEVIER
DOI: 10.1016/j.etap.2017.06.025

关键词

Chronic prostatitis; Urinary dysfunction; SCF/C-kit; Fibrosis; Resveratrol

向作者/读者索取更多资源

Aim: We investigated whether prostate fibrosis was associated with urinary dysfunction in chronic prostatitis (CP) and whether resveratrol improved urinary dysfunction and the underlying molecular mechanism. Methods: Rat model of CP was established via subcutaneous injections of DPT vaccine and subsequently treated with resveratrol. Bladder pressure and volume tests investigated the effect of resveratrol on urinary dysfunction in CP rats. Western blotting and immunohistochemical staining examined the expression level of C-kit/SCF and TGF-beta/Wnt/beta-catenin. Results: Compared to the control group, the maximum capacity of the bladder, residual urine volume and maximum voiding pressure, the activity of C-kit/SCF and TGF-beta/Wnt/beta-catenin pathways were increased significantly in the CP group. Resveratrol treatment significantly improved these factors. Conclusion: CP induced significantly prostate fibrosis, which exhibits a close relationship with urinary dysfunction. Resveratrol improved fibrosis, which may be associated with the suppression of C-kit/SCF and TGF-beta/Wnt/beta-catenin pathway.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据